Hyun Young Woo

Pusan National University Hospital — South Korea

Medicine · Health Sciences

25h-index1.8kcitations112works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(41), Hepatitis C virus research(36), Hepatocellular Carcinoma Treatment and Prognosis(34), Hepatitis B Virus Studies(31), Liver Disease and Transplantation(13)

Publications112 total

Cancer Vaccines in Hepatocellular Carcinoma: Advances, Challenges, and Future Perspectives
Convergence Hepatology·2025Open Access
Long Term Outcomes of Non-operative Treatment for Popliteal Artery Entrapment Syndrome: A Multicentre Study
Journal of Vascular Surgery·2025Open Access
Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C
Journal of Gastroenterology and Hepatology·2025· 2 citedOpen Access
Therapeutic Colorectal Cancer Vaccines: Emerging Modalities and Translational Opportunities
Vaccines·2025· 2 citedOpen Access
Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study
PLoS ONE·2025Open Access
Bepirovirsen for the treatment of chronic hepatitis B infection
Future Virology·2025· 1 cited
Influence Of Gut Microbiota On The Efficacy Of Immune Checkpoint Inhibitors In The Treatment Of Gynecologic Cancers: A Korean Perspective
International Journal of Gynecological Cancer·2025Open Access
THU-516 Beneficial effect of combined radiation therapy in atezolizumab plus bevacizumab treatment of hepatocellular carcinoma patients with main portal vein tumor thrombosis
Journal of Hepatology·2024
Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma
Cancers·2024· 5 citedOpen Access
Real-world experience of atezolizumab plus bevacizumab combination treatment in high risk patients with advanced hepatocellular carcinoma
Journal of Hepatology·2023
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial
Molecular Therapy·2023· 29 citedOpen Access
Recent Advances in Cancer Immunotherapy Delivery Modalities
Pharmaceutics·2023· 27 citedOpen Access
Erratum: Correction of Text in the Article “Seroprevalence of Hepatitis C Virus Infection in North Korean Defectors Residing in Korea”
Journal of Korean Medical Science·2023Open Access
Seroprevalence of Hepatitis C Virus Infection in North Korean Defectors Residing in Korea
Journal of Korean Medical Science·2023Open Access
Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial
PLoS ONE·2022· 2 citedOpen Access
Real-life effectiveness and safety of sofosbuvir/velpatasvir in difficult to treat hepatitis C patients
Journal of Hepatology·2022
Noninvasive prediction of hepatocellular carcinoma development after oral antiviral therapy in patients with chronic hepatitis C: a multicenter study
Journal of Hepatology·2022· 1 cited
Direct acting antiviral agents improve survival in patients with hepatitis C virus related hepatocellular carcinoma
Journal of Hepatology·2022
Safety and dose-escalation study of a targeted oncolytic adenovirus, suratadenoturev (OBP-301), in patients with refractory advanced liver cancer: Phase I clinical trial.
Journal of Clinical Oncology·2022· 2 cited
940P Dose-escalation trial of OBP-301, novel telomerase-specific oncolytic virus in advanced hepatocellular carcinoma
Annals of Oncology·2021
page 1 of 6Next →

Frequent Co-authors

Jeong Heo(27), Si Hyun Bae(20), Seung Kew Yoon(17), Jong Young Choi(14), Jeong Won Jang(11), Mong Cho(11), Chan Ran You(8), Ki Tae Yoon(8), Geun Am Song(7), Jin-Dong Kim(6), Gwang Ha Kim(6), Dong Uk Kim(6), Jong Young Choi(6), So Young Yoo(6), Dae Hwan Kang(6), Won Young Tak(5), Kwang‐Hyub Han(5), Young Mi Hong(5), Young Seok Kim(4), Jung Hyun Kwon(4)